참고문헌
- Choe BH. Management of chronic hepatitis B in children. Proceedings of the 2003 Joint seminar of Korean gastroenterology society; 2003 Sep 21; Seoul. Seoul : The Korean Society of Gastroenterology, 2003:250-61
- Choe BH, Oh KW, Park WS, Lee JH, Kwon S, Ko CW, et al. Comparison of therapeutic efficacy between lamivudine and alpha-interferon in Korean children with chronic hepatitis B. J Pediatr Gastroenterol Nutr 2003;37:379 https://doi.org/10.1097/00005176-200309000-00040
- Sokal EM, Conjeevaram HS, Roberts EA, Alvarez F, Bern EM, Goyens P, et al. Interferon alfa therapy for chronic hepatitis B in children : a multinational randomized controlled trial. Gastroenterology 1998;114:988-95. https://doi.org/10.1016/S0016-5085(98)70318-X
- Jonas MM, Kelley DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002;346:1706-13 https://doi.org/10.1056/NEJMoa012452
- Jonas MM. Interferon-alpha for viral hepatitis. J Pediatr Gastroenterol Nutr 1996;23:93-106 https://doi.org/10.1097/00005176-199608000-00001
- Desmet VJ. Immunopathology of chronic viral hepatitis. Hepatogastroenterology 1991;38:14-21
- Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984 : a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-7 https://doi.org/10.1002/jmv.1890180402
- Hsu HY, Chang MH, Lee CY, Chen JS, Hsu HC, Chen DS. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 1992;15:382-6 https://doi.org/10.1002/hep.1840150304
- Kim Y, Baek S, Eom J, Chung K. Natural history of chronic hepatitis B in children. Korean J Pediatr 2004;47: 282-9
- Perrillo RP. Treatment of chronic hepatitis B with interferon : experience in western countries. Semin Liver Dis 1989; 9:240-8 https://doi.org/10.1055/s-2008-1040517
- Torre D, Tambini R. Interferon-alpha therapy for chronic hepatitis B in children : a meta-analysis. Clin Infect Dis 1996;23:131-7 https://doi.org/10.1093/clinids/23.1.131
- Conjeevaram HS, Di Bisceglie AM. Management of chronic viral hepatitis in children. J Pediatr Gastroenterol Nutr 1995;20:365-75 https://doi.org/10.1097/00005176-199505000-00001
- Jang CH, Lee KH, Hwang WK, Oh KW, Park WS, Lee JH, et al. The comparison of interferon-alpha treatment by dosages and retreatment for chronic hepatitis B in children. Korean J Pediatr Gastroenterol Nutr 2003;6:152-60
- Choe BH, Ko CW. Combined therapy of alfa-interferon and thymodulin on children with chronic active hepatitis B. Korean J Pediatr Gastroenterol Nutr 1998;1:79-89
- Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Longterm beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999;29:971- 5 https://doi.org/10.1002/hep.510290312
- Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Jr., Lindsay K, Payne J, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 1990;323:295- 301 https://doi.org/10.1056/NEJM199008023230503
- Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998;102:968- 75 https://doi.org/10.1172/JCI3731
- Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63 https://doi.org/10.1056/NEJM199910213411702
- Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657- 61 https://doi.org/10.1056/NEJM199512213332501
- Nevens F, Main J, Honkoop P, Tyrrell DL, Barber J, Sullivan MT, et al. Lamivudine therapy for chronic hepatitis B : a six-month randomized dose-ranging study. Gastroenterology 1997;113:1258-63 https://doi.org/10.1053/gast.1997.v113.pm9322520
- Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998;339:61-8 https://doi.org/10.1056/NEJM199807093390201
- Schiff ER, Dienstag JL, Karayalcin S, Grimm IS, Perrillo RP, Husa P, et al. Lamivudine and 24 weeks of lamivudine/ interferon combination therapy for hepatitis B e antigen- positive chronic hepatitis B in interferon nonresponders. J Hepatol 2003;38:818-26 https://doi.org/10.1016/S0168-8278(03)00076-X
- Serfaty L, Thabut D, Zoulim F, Andreani T, Chazouilleres O, Carbonell N, et al. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone : results of a pilot study. Hepatology 2001;34:573-7 https://doi.org/10.1053/jhep.2001.26819
- Wai CT, Chu CJ, Hussain M, Lok AS. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 2002;36:1425-30
- Lee S, Han S, Cho S, Roh B, Sohn J, Kim D, et al. Distribution of HBV genotypes in patients with chronic HBV infection in Korea. Korean J Hepatol 2001;7:373-80
- Cha C, Sohn Y, Jang S, Lee H, Lee K, Shin E, et al. Genotype analysis of hepatitis B virus isolated from Korean hepatitis patients. Korean J Lab Med 2003;23:352-6
- Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, et al. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C. Int J Mol Med 2002;10:201-4
- Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates : results after 3 years of therapy. Hepatology 2001;33:1527-32 https://doi.org/10.1053/jhep.2001.25084
- Song BC, Suh DJ, Lee HC, Chung YH, Lee YS. Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea. Hepatology 2000;32:803-6 https://doi.org/10.1053/jhep.2000.16665
- Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 2000;119:172-80 https://doi.org/10.1053/gast.2000.8559
- Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 1998;27:1670-7 https://doi.org/10.1002/hep.510270628
- Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1998;27:628-33 https://doi.org/10.1002/hep.510270243
- Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001;34:1225-41 https://doi.org/10.1053/jhep.2001.29401
- Moraleda G, Saputelli J, Aldrich CE, Averett D, Condreay L, Mason WS. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 1997;71:9392-9
- Zeuzem S, de Man RA, Honkoop P, Roth WK, Schalm SW, Schmidt JM. Dynamics of hepatitis B virus infection in vivo. J Hepatol 1997;27:431-6 https://doi.org/10.1016/S0168-8278(97)80345-5
- Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C. J Gastroenterol Hepatol 2000;15:825-41 https://doi.org/10.1046/j.1440-1746.2000.02324.x
- Zuccotti GV, Cucchi C, Gracchi V, D'Auria E, Riva E, Tagger A. A 1-year trial of lamivudine for chronic hepatitis B in children. J Int Med Res 2002;30:200-2 https://doi.org/10.1177/147323000203000214
- Selimoglu MA, Aydogdu S, Unal F, Zeytinoglu A, Yuce G, Yagci RV. Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children. Pediatr Int 2002; 44:404-8 https://doi.org/10.1046/j.1442-200X.2002.01589.x
- Lai CL, Lok AS, Lin HJ, Wu PC, Yeoh EK, Yeung CY. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet 1987;2:877-80
- Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56 https://doi.org/10.1056/NEJM199701303360507